A phase I trial of recombinant leukocyte alpha 2 interferon in patients with advanced malignancy.
Muss HB, Richards F 2nd, Homesley HD, Spurr CL, Rudnick SA, Stuart JJ, Plunkett S, Welander C, Caponera M, White DR, et al.
Am J Clin Oncol. 1985 Apr;8(2):97-107.PMID: 3834792 [PubMed - indexed for MEDLINE]Related articles